"Proto-Oncogenes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D011519
						 | 			
					
					
						| MeSH Number(s) | 
						
							 G05.360.340.024.340.375.500.791 
						 | 
					
					
						| Concept/Terms | 
						
							
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Proto-Oncogenes".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogenes".
				
					
						- Proto-Oncogenes
 - Genes, abl
 - Genes, bcl-1
 - Genes, bcl-2
 - Genes, erbA
 - Genes, erbB
 - Genes, fms
 - Genes, fos
 - Genes, jun
 - Genes, mos
 - Genes, myb
 - Genes, myc
 - Genes, ras
 - Genes, rel
 - Genes, sis
 - Genes, src
 
					
				 
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Proto-Oncogenes" by people in this website by year, and whether "Proto-Oncogenes" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2004 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Proto-Oncogenes" by people in Profiles.
						
					
								- 
								
Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. Leuk Res. 2004 Aug; 28(8):791-803.
															
								 
							
								- 
								
Chemical induction of thymomas in AKR mice: interaction of chemical carcinogens and endogenous murine leukemia viruses. Comparison of N-methyl-N-nitrosourea and methyl methanesulphonate. Mol Carcinog. 1990; 3(3):126-33.
															
								 
							
								- 
								
Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer. Immunol Ser. 1990; 53:453-68.
															
								 
							
								- 
								
Molecular genetic analysis reveals chromosomal deletion, gene amplification, and autocrine growth factor production in the pathogenesis of human lung cancer. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 2:843-53.